Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin.
Clin Drug Investig
; 38(11): 1001-1009, 2018 Nov.
Article
in En
| MEDLINE
| ID: mdl-30171457
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bridged Bicyclo Compounds
/
Liver Diseases
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Drug Investig
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2018
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Nueva Zelanda